Anavex Life Sciences announced plans to continue to screen and enroll patients into its active trials for Alzheimer’s disease…
Articles by Patricia Inacio, PhD
Moderate lifetime alcohol intake in middle-aged and older people who don’t show signs of dementia is associated with lower deposits…
A Phase 2 clinical trial testing Annovis Bio’s oral therapy ANVS401 (also known as Posiphen) in people…
The National Institutes of Health (NIH) has awarded a $4.8-million grant to support a project designed to discover how…
The U.S. Food and Drug Administration (FDA) has agreed to review a new drug application (NDA) for Adlarity —…
The levels of circular RNAs in the brains of patients with Alzheimer’s disease are linked to several traits and clinical…
A new screening assay has identified small molecules capable of protecting brain mitochondria from stress conditions that commonly occur in…
A protein involved in ovarian cancer, known as OCIAD1, contributes to the neurodegeneration seen in Alzheimer’s disease, and may…
Immunization with two experimental vaccines targeting the toxic forms of amyloid-beta and tau protein — two hallmarks of …
Troriluzole, an investigational oral therapy by Biohaven, shows a potential to improve cognition and lessen brain volume loss,…